(Q70168077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Salvage chemotherapy containing moderate-dose cytosine arabinoside and mitoxantrone for relapsed and resistant acute myeloid leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

1 reference

R Liang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

E Chiu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

T K Chan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

D Todd

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

74-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00684961

9 October 2019

exact match

0 references

cites work

Phase II trial of mitoxantrone in refractory acute leukemia

1 reference

12 December 2020

Induction chemotherapy for newly diagnosed acute myeloid leukaemia using a regime containing cytosine arabinoside, daunorubicin and etoposide

1 reference

12 December 2020

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

12 December 2020

Therapy of acute myelogenous leukemia

1 reference

12 December 2020

Mitoxantrone in patients with acute leukemia in relapse

1 reference

12 December 2020

Chemotherapy for relapsed and resistant acute nonlymphoblastic leukemia. Effect of ATA, an amsacrine-containing regime.

1 reference

12 December 2020

Mitoxantrone for refractory and relapsed acute leukemia

1 reference

12 December 2020

Mitoxantrone in the treatment of relapsed and refractory acute leukemia.

1 reference

12 December 2020

Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia

1 reference

12 December 2020

Treatment of patients with acute nonlymphocytic leukemia not in remission

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00684961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040037%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference